The association between sarcopenia and clinical outcomes among Chinese patients with triple-negative breast cancer: a retrospective study
Authors:
Open Access
- 6 February 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1402300
Abstract
Purpose: This study efforts to explore the association between sarcopenia, an age-related decline in muscle mass and physical function, and clinical outcomes in women with triple-negative breast cancer (TNBC).Methods and materials: This retrospective study included women diagnosed with TNBC who received breast surgery from December 2012 to December 2018. Skeletal muscle mass index (SMI) is utilized to evaluate sarcopenia, which was quantified by the cross-sectional area of muscle at the twelfth thoracic vertebra (T12). Disease-free survival (DFS) and overall survival (OS) are the endpoints. The association of sarcopenia with DFS and OS was statistically analyzed.Results: The study included 130 women in all, with a median age of 55 years (median follow-up, 53 months). Among them, 78 (58.5%) women had sarcopenia (SMI <28.01). 38 patients (29.2%) died and 49 patients (37.7%) experienced a recurrence of breast cancer throughout the follow-up period. Sarcopenia was demonstrated to be a significant predictive factor for both OS (HR,2.885; 95% CI, 1.349–6.169; p = 0.006) and DFS (HR,3.121; 95% CI, 1.578–6.175; p = 0.001) in the multivariate Cox proportional hazard model. There was no significant correlation seen between body mass index and either DFS (p = 0.156) or OS (P = 0.264). Logistic regression model further revealed that sarcopenia was a prognostic factor that was independently associated with both DFS (p = 0.001) and OS (p = 0.006).Conclusions: Among women with TNBC, sarcopenia is associated with worse clinical outcomes. These patients with high risk might be candidates for individual programmed exercise and diet interventions to optimize survival outcomes.Keywords
This publication has 46 references indexed in Scilit:
- Protein supplementation improves lean body mass in physically active older adults: a randomized placebo‐controlled trialJournal of Cachexia, Sarcopenia and Muscle, 2019
- Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast CancerJAMA Oncology, 2018
- Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal CancerJAMA Oncology, 2017
- Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training interventionBreast Cancer Research and Treatment, 2017
- Impact of body composition on outcome in patients with early breast cancerSupportive Care in Cancer, 2017
- Diagnosing Sarcopenia on Thoracic Computed TomographyAcademic Radiology, 2017
- Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapyThe Breast, 2017
- Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trialBreast Cancer Research and Treatment, 2016
- Mortality as an adverse outcome of sarcopeniaThe Journal of nutrition, health and aging, 2013
- Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL StudyJournal of Cancer Survivorship, 2012